4th Quarter - Amendment

ACG ADVOCACY for JUNO THERAPEUTICS, INC.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 23, 2017 $50,000 Replaced
4th Quarter - Amendment (this page) Feb 2, 2017 $50,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Innovation and investment issues impacting Juno Therapeutics.

LobbyistCovered position, as disclosed
MARY O'DEA AHEARN ALLEN —
MANUS COONEY Staff Director & Chief Counsel, Senate Judiciary Committee
CHRIS ISRAEL U.S. Coordinator for International IP Enforcement; Deputy Chief of Staff, Department of Commerce; Deputy Assistant Secretary for Tech Policy, Department of Commerce
JULIE PHILP LD, Rep. John Campbell; LA/Senior LA, Rep. Gil Gutknecht; LA and Scheduler, Rep. Michael Burgess; LA, Scheduler, Rep. Connie Morella; LA, Ileana Ros-Lehtinen
STEPHEN PINKOS Policy Dir/Gen Counsel, House Majority Whip Kevin McCarthy; Deputy Undersecretary of Commerce for IP; Staff Director, House Judiciary Committee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.